Beckley Foundation

Mission Statement

The Beckley Foundation is UK-based non-profit with a long history of pioneering psychedelic research. Founder and Director Amanda Feilding has for the past years been laying the groundwork for an exciting new range of collaborations with leading research institutes around the world, largely focusing on LSD. "Following ground-breaking research, conducted notably in collaboration with the Imperial College, with the first fMRI studies of psilocybin, LSD and DMT, and the first clinical study on psilocybin-assisted therapy for depression, I have for the past years been laying the groundwork for an exciting new range of collaborations with leading research institutes around the world, largely focusing on LSD, a compound I consider the ‘Queen of psychedelics’.” - Amanda Feilding As part of this new programme, the Beckley Foundation will examine the mechanisms underlying the LSD-induced mystical experience using the latest neuroimaging technology. This work will shed some important light on the mysterious relationship between the mystical experience and the long-term positive therapeutic outcomes of psychedelic-assisted therapy that our previous research has observed.